Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Fabio Stellari (Parma, Italy), Gino Villetti, Yanto Ridwan, Sasha Belenkov, Jeroen Essers, Francesca Ruscitti, Francesca Ravenetti, Paula Van Heiningen, Wim Wos, Cedric Van Holsbeke, Maurizio Civelli, Fabio Stellari. Longitudinal assessment of lung fibrosis by micro CT correlates with histological evaluation in bleomycin-induced mice. Eur Respir J 2016; 48: Suppl. 60, 3505

Member's Comments

No comment yet.

Related content which might interest you: Longitudinal assessment in combined pulmonary fibrosis and emphysema (CPFE): a case series Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing Source: International Congress 2015 – New insights into IIPs Year: 2015 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Automated histological image analysis for the assessment of bleomycin-induced pulmonary fibrosis in rodents Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Longitudinal structural changes using MDCT in patients with combined pulmonary fibrosis with emphysema Source: Virtual Congress 2021 – Imaging Year: 2021 Interstitial lung abnormalities in the AGES-Reykjavik study Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Lung clearance Index changes over time among patients with cystic fibrosis Source: International Congress 2015 – New findings in paediatric respiratory physiology Year: 2015 HRCT in the evaluation of functional decay in IPF Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Do typical and atypical HRCT patterns make difference in prognosis of patients with IPF? Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Comparison of densitometric and visual scoring in the assessment of severity of idiopathic fibrotic interstitial pneumonias: Preliminary observations Source: International Congress 2015 – New insights into IIPs Year: 2015 Structural lung disease, pulmonary infection and inflammation in infancy is associated with reduced spirometry at school-age in children with cystic fibrosis (CF) Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013 Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Clinical profile and early follow-up of patients receiving pirfenidone in the PIONEER observational study Source: International Congress 2014 – ILDs 6 Year: 2014